These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 36304540)

  • 1. A systematic review and meta-analysis of sacubitril-valsartan in the treatment of ventricular remodeling in patients with heart failure after acute myocardial infarction.
    Zhou X; Zhu H; Zheng Y; Tan X; Tong X
    Front Cardiovasc Med; 2022; 9():953948. PubMed ID: 36304540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sacubitril-valsartan on left ventricular remodeling in patients with acute myocardial infarction after primary percutaneous coronary intervention: a systematic review and meta-analysis.
    Liu Y; Sun Y; Dai W
    Front Pharmacol; 2024; 15():1366035. PubMed ID: 38863978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis.
    Yang P; Han Y; Lian C; Wu X
    Front Cardiovasc Med; 2022; 9():988117. PubMed ID: 36093128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects and safety of early use of sacubitril/valsartan after acute myocardial infarction: a systematic review and meta-analysis.
    Zhang L; Yan K; Zhao H; Shou Y; Chen T; Chen J
    Ann Palliat Med; 2022 Mar; 11(3):1017-1027. PubMed ID: 35365031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of early administration of sacubitril/valsartan after coronary artery revascularization in patients with acute myocardial infarction complicated by moderate-to-severe mitral regurgitation: a randomized controlled trial.
    Yin H; Ma L; Zhou Y; Tang X; Li R; Zhou Y; Shi J; Zhang J
    Heart Vessels; 2024 Aug; 39(8):673-686. PubMed ID: 38635062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.
    Liu H; Su Y; Shen J; Jiao Y; Li Y; Liu B; Hou X; Jin Q; Chen Y; Sun Z; Xi Q; Feng B; Fu Z
    ESC Heart Fail; 2024 Apr; 11(2):937-949. PubMed ID: 38224955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benefits of sacubitril-valsartan in patients with acute myocardial infarction: a systematic review and meta-analysis.
    Xiong B; Nie D; Qian J; Yao Y; Yang G; Rong S; Zhu Q; Du Y; Jiang Y; Huang J
    ESC Heart Fail; 2021 Dec; 8(6):4852-4862. PubMed ID: 34716749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis.
    Liu L; Ding X; Han Y; Lv J
    J Healthc Eng; 2022; 2022():7840852. PubMed ID: 35035857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of early initiation of Sacubitril/Valsartan in patients after acute myocardial infarction: A meta-analysis.
    Zhao J; Zeng Y; Shen X
    Clin Cardiol; 2021 Oct; 44(10):1354-1359. PubMed ID: 34464468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis.
    Xiang Q; Wang M; Ding Y; Fan M; Tong H; Chen J; Yu P; Shen L; Chen X
    Front Pharmacol; 2022; 13():832782. PubMed ID: 35444529
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy and safety of sacubitril/valsartan compared with ACEI/ARB in the treatment of heart failure following acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials.
    Gao J; Zhang X; Xu M; Deng S; Chen X
    Front Pharmacol; 2023; 14():1237210. PubMed ID: 37601056
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of sacubitril/valsartan on cardiac reverse remodeling and cardiac resynchronization in patients with acute myocardial infarction.
    Yang P; Li X; Wang L; Wu X; Wang C; Li T; Wang H
    Front Cardiovasc Med; 2022; 9():1059420. PubMed ID: 36712243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sacubitril-valsartan on heart failure patients with mid-range ejection fractions: A systematic review and meta-analysis.
    Qin J; Wang W; Wei P; Huang P; Lin R; Yue J
    Front Pharmacol; 2022; 13():982372. PubMed ID: 36353496
    [No Abstract]   [Full Text] [Related]  

  • 14. The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis.
    Kotak S; Hassan W; Mehmood M; Kumar U; Sagreeka F; Karishma F; Kumari P; Pirya F; Saquib J; Iqbal A; Khan AA; Varrassi G; Khatri M; Kumar S
    Cureus; 2023 Oct; 15(10):e46547. PubMed ID: 37933369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of early initiation of sacubitril-valsartan therapy in patients with acute decompensated heart failure].
    Si JP; Chen YW; Yang J; Li X; Zhang YL; Liu JQ; Guo R; Wang K; Jiang YN; Xia YL; Liu Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jun; 48(6):477-483. PubMed ID: 32842257
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction.
    Januzzi JL; Prescott MF; Butler J; Felker GM; Maisel AS; McCague K; Camacho A; Piña IL; Rocha RA; Shah AM; Williamson KM; Solomon SD;
    JAMA; 2019 Sep; 322(11):1085-1095. PubMed ID: 31475295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination pharmacotherapies for cardiac reverse remodeling in heart failure patients with reduced ejection fraction: A systematic review and network meta-analysis of randomized clinical trials.
    Bao J; Kan R; Chen J; Xuan H; Wang C; Li D; Xu T
    Pharmacol Res; 2021 Jul; 169():105573. PubMed ID: 33766629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the application effect of bisoprolol combined with sacubitril valsartan sodium tablets in the cardiac rehabilitation of patients with acute myocardial infarction combined with left heart failure after percutaneous coronary intervention (PCI).
    Chen C; Wu X; Li Y; Peng Y
    Ann Palliat Med; 2021 May; 10(5):5455-5461. PubMed ID: 34044572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Sacubitril/Valsartan on renal function in patients with chronic kidney disease and heart failure with preserved ejection fraction: A real-world 12-week study.
    Jia R; Zhang X; Xu Y; Zheng Z; Jiang L; Zhang X; Sun C; Wu X; Li S; Raj A; Sun D
    Eur J Pharmacol; 2022 Aug; 928():175053. PubMed ID: 35709921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficacy and Safety of a Qiliqiangxin Capsule Combined with Sacubitril/Valsartan in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis.
    Chen W; Chang H; Wang X; Wang Y; Liu Y; Wang D
    Evid Based Complement Alternat Med; 2023; 2023():2701314. PubMed ID: 36777628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.